GERD evaluation

Time for a new paradigm?

Irvin M. Modlin, Peter Malfertheiner, Richard H. Hunt, David Armstrong, Gerald Holtmann, Eamon M. Quigley, Stuart J. Spechler

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In the past there has been reliance on heartburn and acid regurgitation as the cardinal symptoms of gastro-esophageal reflux. Now it is recognized that diverse additional symptoms including extraesophageal manifestations are essential components of gastroesophageal reflux disease (GERD). Furthermore, previous reliance in mucosal damage at endoscopy as evidence of therapeutic success in the management of GERD has proven of only limited value in the diverse world of GERD symptoms. Indeed is now apparent that the relationship between symptoms and lesions is modest at best. Most patients with GERD have no overt erosions or ulceration at endoscopy and they frequently suffer from a wide array of complaints other than heartburn that contribute to their diminished perception of life's quality. To address these problems, multidimensional questionnaires designed to encompass the diverse symptomatology of GERD have been investigated, principally, to provide a reproducible metric of change in the subjective response to pharmacologic therapy during trials for patients with nonerosive reflux disease. The most promising of these instruments is The ReQuest questionnaire, because it has been extensively validated in multiple patient groups and cultures, appears highly promising in this regard and for erosive disease too and may ultimately prove to be of value for the initial evaluation of patients with GERD. We propose that accurate symptom delineation complemented with endoscopy performed in selected groups of patients will become the mainstay in diagnosis of GERD and the assessment of therapy efficacy.

Original languageEnglish (US)
Pages (from-to)237-241
Number of pages5
JournalJournal of Clinical Gastroenterology
Volume41
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Gastroesophageal Reflux
Endoscopy
Heartburn
Therapeutics
Quality of Life
Acids

Keywords

  • Dyspepsia
  • Evaluation
  • GERD
  • NERD
  • ReQuest
  • Symptom

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Modlin, I. M., Malfertheiner, P., Hunt, R. H., Armstrong, D., Holtmann, G., Quigley, E. M., & Spechler, S. J. (2007). GERD evaluation: Time for a new paradigm? Journal of Clinical Gastroenterology, 41(3), 237-241. https://doi.org/10.1097/01.mcg.0000225693.69745.49

GERD evaluation : Time for a new paradigm? / Modlin, Irvin M.; Malfertheiner, Peter; Hunt, Richard H.; Armstrong, David; Holtmann, Gerald; Quigley, Eamon M.; Spechler, Stuart J.

In: Journal of Clinical Gastroenterology, Vol. 41, No. 3, 03.2007, p. 237-241.

Research output: Contribution to journalArticle

Modlin, IM, Malfertheiner, P, Hunt, RH, Armstrong, D, Holtmann, G, Quigley, EM & Spechler, SJ 2007, 'GERD evaluation: Time for a new paradigm?', Journal of Clinical Gastroenterology, vol. 41, no. 3, pp. 237-241. https://doi.org/10.1097/01.mcg.0000225693.69745.49
Modlin IM, Malfertheiner P, Hunt RH, Armstrong D, Holtmann G, Quigley EM et al. GERD evaluation: Time for a new paradigm? Journal of Clinical Gastroenterology. 2007 Mar;41(3):237-241. https://doi.org/10.1097/01.mcg.0000225693.69745.49
Modlin, Irvin M. ; Malfertheiner, Peter ; Hunt, Richard H. ; Armstrong, David ; Holtmann, Gerald ; Quigley, Eamon M. ; Spechler, Stuart J. / GERD evaluation : Time for a new paradigm?. In: Journal of Clinical Gastroenterology. 2007 ; Vol. 41, No. 3. pp. 237-241.
@article{1e60579b84e44768bf3380b19aa6ec90,
title = "GERD evaluation: Time for a new paradigm?",
abstract = "In the past there has been reliance on heartburn and acid regurgitation as the cardinal symptoms of gastro-esophageal reflux. Now it is recognized that diverse additional symptoms including extraesophageal manifestations are essential components of gastroesophageal reflux disease (GERD). Furthermore, previous reliance in mucosal damage at endoscopy as evidence of therapeutic success in the management of GERD has proven of only limited value in the diverse world of GERD symptoms. Indeed is now apparent that the relationship between symptoms and lesions is modest at best. Most patients with GERD have no overt erosions or ulceration at endoscopy and they frequently suffer from a wide array of complaints other than heartburn that contribute to their diminished perception of life's quality. To address these problems, multidimensional questionnaires designed to encompass the diverse symptomatology of GERD have been investigated, principally, to provide a reproducible metric of change in the subjective response to pharmacologic therapy during trials for patients with nonerosive reflux disease. The most promising of these instruments is The ReQuest questionnaire, because it has been extensively validated in multiple patient groups and cultures, appears highly promising in this regard and for erosive disease too and may ultimately prove to be of value for the initial evaluation of patients with GERD. We propose that accurate symptom delineation complemented with endoscopy performed in selected groups of patients will become the mainstay in diagnosis of GERD and the assessment of therapy efficacy.",
keywords = "Dyspepsia, Evaluation, GERD, NERD, ReQuest, Symptom",
author = "Modlin, {Irvin M.} and Peter Malfertheiner and Hunt, {Richard H.} and David Armstrong and Gerald Holtmann and Quigley, {Eamon M.} and Spechler, {Stuart J.}",
year = "2007",
month = "3",
doi = "10.1097/01.mcg.0000225693.69745.49",
language = "English (US)",
volume = "41",
pages = "237--241",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - GERD evaluation

T2 - Time for a new paradigm?

AU - Modlin, Irvin M.

AU - Malfertheiner, Peter

AU - Hunt, Richard H.

AU - Armstrong, David

AU - Holtmann, Gerald

AU - Quigley, Eamon M.

AU - Spechler, Stuart J.

PY - 2007/3

Y1 - 2007/3

N2 - In the past there has been reliance on heartburn and acid regurgitation as the cardinal symptoms of gastro-esophageal reflux. Now it is recognized that diverse additional symptoms including extraesophageal manifestations are essential components of gastroesophageal reflux disease (GERD). Furthermore, previous reliance in mucosal damage at endoscopy as evidence of therapeutic success in the management of GERD has proven of only limited value in the diverse world of GERD symptoms. Indeed is now apparent that the relationship between symptoms and lesions is modest at best. Most patients with GERD have no overt erosions or ulceration at endoscopy and they frequently suffer from a wide array of complaints other than heartburn that contribute to their diminished perception of life's quality. To address these problems, multidimensional questionnaires designed to encompass the diverse symptomatology of GERD have been investigated, principally, to provide a reproducible metric of change in the subjective response to pharmacologic therapy during trials for patients with nonerosive reflux disease. The most promising of these instruments is The ReQuest questionnaire, because it has been extensively validated in multiple patient groups and cultures, appears highly promising in this regard and for erosive disease too and may ultimately prove to be of value for the initial evaluation of patients with GERD. We propose that accurate symptom delineation complemented with endoscopy performed in selected groups of patients will become the mainstay in diagnosis of GERD and the assessment of therapy efficacy.

AB - In the past there has been reliance on heartburn and acid regurgitation as the cardinal symptoms of gastro-esophageal reflux. Now it is recognized that diverse additional symptoms including extraesophageal manifestations are essential components of gastroesophageal reflux disease (GERD). Furthermore, previous reliance in mucosal damage at endoscopy as evidence of therapeutic success in the management of GERD has proven of only limited value in the diverse world of GERD symptoms. Indeed is now apparent that the relationship between symptoms and lesions is modest at best. Most patients with GERD have no overt erosions or ulceration at endoscopy and they frequently suffer from a wide array of complaints other than heartburn that contribute to their diminished perception of life's quality. To address these problems, multidimensional questionnaires designed to encompass the diverse symptomatology of GERD have been investigated, principally, to provide a reproducible metric of change in the subjective response to pharmacologic therapy during trials for patients with nonerosive reflux disease. The most promising of these instruments is The ReQuest questionnaire, because it has been extensively validated in multiple patient groups and cultures, appears highly promising in this regard and for erosive disease too and may ultimately prove to be of value for the initial evaluation of patients with GERD. We propose that accurate symptom delineation complemented with endoscopy performed in selected groups of patients will become the mainstay in diagnosis of GERD and the assessment of therapy efficacy.

KW - Dyspepsia

KW - Evaluation

KW - GERD

KW - NERD

KW - ReQuest

KW - Symptom

UR - http://www.scopus.com/inward/record.url?scp=33847346880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847346880&partnerID=8YFLogxK

U2 - 10.1097/01.mcg.0000225693.69745.49

DO - 10.1097/01.mcg.0000225693.69745.49

M3 - Article

VL - 41

SP - 237

EP - 241

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 3

ER -